Application of NCCN guidelines in PD-L1 expression for patients with stage IV non-small cell lung cancer.

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. e15030-e15030

Journal article published in 2018 by Ilana Schlam, Karyn M. Dyehouse, Patrick J. Ward

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by